Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.

Xavier BadiaPeter TrainerNienke R BiermaszJitske TiemensmaAgata CarreñoMontserrat RosetAnna ForsytheSusan M Webb

Published in: Journal of medical economics (2018)

A mapping algorithm was developed for mapping of AcroQoL to EQ-5D, using patient level data from three previously published studies, and including validation in the confirmatory sub-sample. Mean (SD) utilities index in this study population was estimated as 0.71 (0.28). Additional research may be needed to test this mapping algorithm in other acromegaly populations.

Keyphrases

high resolution
high density
machine learning
deep learning
randomized controlled trial
systematic review
mass spectrometry
growth hormone
case control
genetic diversity